These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4170 related articles for article (PubMed ID: 25075903)

  • 41. CRISPR interference (CRISPRi) for sequence-specific control of gene expression.
    Larson MH; Gilbert LA; Wang X; Lim WA; Weissman JS; Qi LS
    Nat Protoc; 2013 Nov; 8(11):2180-96. PubMed ID: 24136345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 43. High-throughput functional genomics using CRISPR-Cas9.
    Shalem O; Sanjana NE; Zhang F
    Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
    Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
    Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of eGFP and Cre knockin rats by CRISPR/Cas9.
    Ma Y; Ma J; Zhang X; Chen W; Yu L; Lu Y; Bai L; Shen B; Huang X; Zhang L
    FEBS J; 2014 Sep; 281(17):3779-90. PubMed ID: 25039742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. More specific CRISPR editing.
    de Souza N
    Nat Methods; 2014 Jul; 11(7):712. PubMed ID: 25110782
    [No Abstract]   [Full Text] [Related]  

  • 48. Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders.
    Wan T; Ping Y
    Adv Drug Deliv Rev; 2021 Jan; 168():196-216. PubMed ID: 32416111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral Delivery Systems for CRISPR.
    Xu CL; Ruan MZC; Mahajan VB; Tsang SH
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30621179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Introduction to CRISPR Technology for Genome Activation and Repression in Mammalian Cells.
    Du D; Qi LS
    Cold Spring Harb Protoc; 2016 Jan; 2016(1):pdb.top086835. PubMed ID: 26729914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.
    Evers B; Jastrzebski K; Heijmans JP; Grernrum W; Beijersbergen RL; Bernards R
    Nat Biotechnol; 2016 Jun; 34(6):631-3. PubMed ID: 27111720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new world order: tailored gene targeting and regulation using CRISPR.
    Weinberg MS; Morris KV
    Mol Ther; 2014 May; 22(5):893. PubMed ID: 24787973
    [No Abstract]   [Full Text] [Related]  

  • 56. CRISPR-Cas12a: Functional overview and applications.
    Paul B; Montoya G
    Biomed J; 2020 Feb; 43(1):8-17. PubMed ID: 32200959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
    Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
    RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of Cas8 in type I CRISPR interference.
    Cass SD; Haas KA; Stoll B; Alkhnbashi OS; Sharma K; Urlaub H; Backofen R; Marchfelder A; Bolt EL
    Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
    Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
    J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.
    Schmid-Burgk JL; Chauhan D; Schmidt T; Ebert TS; Reinhardt J; Endl E; Hornung V
    J Biol Chem; 2016 Jan; 291(1):103-9. PubMed ID: 26553871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 209.